Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines

Urology

Volumn 55, Issue 6, 2000, Pages 951-955

  Ikemoto, Shinichi ^a   Sugimura, Kazunobu ^a   Yoshida, Naomasa ^a   Yasumoto, Ryouji ^a   Wada, Seiji ^a   Yamamoto, Keisuke ^a   Kishimoto, Taketoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALEIN; BAICALIN; SCUTELLARIAE RADIX; WOGONIN;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; FLAVANONES; FLAVONOIDS; HUMANS; MALE; MICE; MICE, INBRED C3H; TUMOR CELLS, CULTURED;

EID: 0034025809     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00467-2     Document Type: Article

References (25)

1. Kimura Y., Kubo M., Yani T., et al. Studies on Scutellariae radix. IV. Effects on lipid peroxidation in rat liver. Chem Pharm Bull. 29:1981;2610-2617.
2. Ryu SH: Anti-tumor activity of flavones with special reference to Skullcapflavon II. PhD Dissertation. Seoul, Korea, Korea Advanced Institute of Science and Technology, 1985, pp 1-122.
3. Sekiya K., Okada H. Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun. 105:1982;1090-1095.
4. Takasuna K., Kasai Y., Kitano Y., et al. Protective effects of Kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11) in rats. Jpn J Cancer Res. 86:1995;978-984.
5. Yokozawa T., Dong E., Kawai Y., et al. Protective effects of some flavonoids on the renal cellular membrane. Exp Toxicol Pathol. 51:1999;9-14.
6. Baylor N.W., Fu T., Yan Y.D., et al. Inhibition of human T cell leukemia virus by the plant flavonoid baicalin (7-glucuronic acid 5,6-dihydroxyflavone). J Infect Dis. 165:1992;433-437.
7. Wu X., Akatsu H., Okada H. Apoptosis of HIV-infected cells following treatment with sho-saiko-to and its components. Jpn J Med Sci Biol. 48:1995;79-87.
8. Okita K., Li Q., Murakami T., et al. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur J Cancer Prev. 2:1993;169-176.
9. 1 phase. Cancer Res. 54:1994;448-454.
10. Matsuzaki Y., Kurokawa N., Terai S., et al. Cell death induced by baicalein in human hepatocellular carcinoma cell lines. Jpn J Cancer Res. 87:1996;170-177.
11. Fukutake M., Yokota S., Kawamura H., et al. Inhibitory effect of Coptidis rhizoma and Scutellariae radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biol Pharm Bull. 21:1998;814-817.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays . J Immunol Methods. 65:1983;55-63.
13. Kitamura M., Mizoguchi Y., Yamamoto S., et al. Anti-tumor activities of macrophages in mice administered Sho-saiko-to. J Med Pharm Soc Wakan Yaku. 2:1985;32-38.
14. Ito H., Shimura K. Effects of a blended Chinese medicine, Xiao-Chai-Hu-Tang on Lewis lung carcinoma growth and inhibition of lung metastasis with special reference to macrophage activation. Jpn J Pharmacol. 41:1986;307-314.
15. Haranaka R., Kosoto H., Hirama N., et al. Antitumor activities of Juzen-taiho-to and cinnamomi cortex. J Med Pharm Soc Wakan Yaku. 4:1987;49-58.
16. Tatsuta M., Ishii H., Baba M., et al. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats. Jpn J Cancer Res. 82:1991;987-992.
17. Maruyama H., Takemoto N., Maruyama N., et al. Antitumour effect of Juzen-taiho-to, a Kampo medicine, combined with surgical excision for transplanted Meth-A fibrosarcoma. Int J Immunotherapy. 9:1993;117-125.
18. Sakamoto S., Mori T., Sawaki K. Effects of Kampo (Japanese herbal) medicine sho-saiko-to on DNA-synthesizing enzyme activity in 1,2-dimethylhydrazine-induced colonic carcinomas in rats. Planta Med. 59:1993;152-154.
19. Oka H., Yamamoto S., Kutoki T., et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer. 76:1995;743-749.
20. Mizoguchi Y., Fujinobu Y., Kobayashi K., et al. The effects of xiao-chai-hu-tang (syo-saiko-to) on natural killer (NK) cell activity. J Med Pharm Soc. 3:1986;184-188.
21. Kumazawa Y., Takimoto H., Miura S., et al. Activation of murine peritoneal macrophage by intraperitoneal administration of a traditional Chinese herbal medicine, Xiao-Chai-Hu-Tang (Japanese name shosaiko-to) . Int J Immunopharmacol. 10:1988;395-403.
22. Yamashiki M., Nishimura A., Hamaguchi K., et al. Effect of Kampo medicine "Sho-Saiko-To" on in vitro cytokine production by peripheral blood mononuclear cells in patients with cancer. Mie Med J. 42:1992;223-227.
23. Uchida E., Fukasawa I., Matsuzaki Y., et al. Pharmacokinetics and pharmacodynamics of TJ-9 after single administration in Japanese healthy male volunteers. Jpn Pharmacol Ther. 23:1995;107-118.
24. Muto R., Motozuka T., Nakano M., et al. The chemical structure of new substance as the metabolite of baicalin and time profiles for the plasma concentration after oral administration of Sho-Saiko-To in human. Yakugaku Zasshi. 118:1998;79-87.
25. Taniguchi C., Homma M., Oka K., et al. Identification of urinary excrements after administration of three Saiko-remedies and comparison between their elimination profiles. Jpn J TDM. 11:1994;113-120.